Kura Oncology moved up less than 1% today. The market isn't being very decisive in its valuation of Biotechnology company.
It looks like Kura Oncology isn't currently at a very decisive point in regards to support/resistance levels. Kura Oncology has looked pretty good over the last few months. It has definitely cuaght a bid and had a nice run. Over the last 3 months, shareholders are no doubt pleased to see a 41.63 percent return. KURA might find some support at the 12.81 level, buyers might push the price back up from here. But it's not very clear what will happen.
The balance of viewpoints by the analysts is positive. The current Analysts Sentiment Score is 84.83. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Mizuho initiated a rating of Buy on 2023-12-22 and added a price target of $26.00. On 2023-12-08 HC Wainwright reiterated their rating of Buy and added a price target of $32.00. Wedbush provided a price target decease of -7.5% to $37.00 from $40.00 on 2023-11-03. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2023-09-07 and they set their price target at $30.00. Bank of America announced that they are initiating coverage with a rating of Buy on 2023-08-11 and added a price target of $31.00. On 2023-07-27 Scotiabank started covering Kura Oncology with a rating of Sector Perform and they set their price target at $10.50.On 2023-06-12 Stifel Nicolaus increased their price target by 4.17% to $25.00. On 2023-05-16 BTIG Research started covering Kura Oncology with a rating of Buy and added a price target of $31.00. JMP Securities reiterated a rating of Market Outperform on 2023-04-17 and added a price target of $22.00.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
KURA | 84.83 | 85.78 | 0 | 86.83 | -2.95 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
KURA | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
KURA | 7.89 | %9.35998 | 7.2 | -7.524 | 6230000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 106 | 0.40 | 2.02 | -4.95 | 13.51 | 39.35 | 30.64 | 37.86 | 34.18 | 14.96 | 13.67 | -13850.04 | -11280.96 | 3.30 | 23.58 | 9.55 | 73.63 |
Healthcare | 249 | 0.71 | 2.38 | -0.94 | 9.19 | 25.06 | 19.39 | 41.77 | 31.77 | 11.23 | 11.41 | -12872.42 | -11623.08 | 4.92 | 17.17 | 6.93 | 53.26 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
KURA |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RCKT | Rocket Pharmaceuticals, I | 0.99 | -1.14 | -0.99 | -11.76 | -6.13 | 29.89 | 60.84 | 38 | 12.18 | 32.42 | 36.89 | -2746.04 | -17665.95 | 0 | 0 | 9.12889 |
DNLI | Denali Therapeutics Inc. | 0.98 | -1.20 | 4.59 | -1.63 | 0.93 | -2.10 | -11.13 | 44 | -10.54 | -23.64 | -26.73 | -17158.84 | -1907.18 | 0 | 0 | 11.2371 |
KALV | KalVista Pharmaceuticals, | 0.94 | 7.14 | 0.08 | -16.12 | -2.23 | 22.77 | 59.19 | 19 | 32.40 | 24.15 | 62.52 | -3314.34 | -9720.48 | 0 | 0 | 16.0787 |
AGIO | Agios Pharmaceuticals, In | 0.94 | 0.41 | -2.14 | -9.39 | 21.73 | 18.05 | 26.42 | 25 | 23.39 | 18.06 | 24.02 | -1989.44 | -8886.57 | 0 | 150 | 10.8809 |
FATE | Fate Therapeutics, Inc. | 0.92 | 0.00 | 11.04 | -5.17 | 107.34 | 236.70 | 32.25 | 42 | 190.86 | 48.02 | 32.47 | -27079.19 | -7042.22 | 0 | 0 | 7.69285 |
KNSA | Kiniksa Pharmaceuticals, | 0.92 | -1.30 | -1.20 | -9.25 | -1.25 | 13.26 | 76.95 | 38 | 105.93 | 47.24 | 80.68 | -1837.89 | 167.32 | 0 | 0 | 10.049 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.